微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 46.32% | -8.31% | -2.75% | 39/55 | 65.82% | 我武生物 | 95.37% | 行业排名> |
| 2025-06-30 | 47.63% | -5.12% | -0.9% | 41/55 | 67.7% | 我武生物 | 95.1% | 行业排名> |
| 2025-03-31 | 48.06% | -6.53% | -2.18% | 40/55 | 69.02% | 金迪克 | 95.24% | 行业排名> |
| 2024-12-31 | 49.13% | -4.56% | -2.74% | 42/55 | 68.55% | 我武生物 | 95.16% | 行业排名> |
| 2024-09-30 | 50.52% | 0.93% | 0.64% | 42/55 | 69.18% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 50.2% | 2.97% | -2.38% | 42/55 | 68.3% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 51.42% | 6.21% | -0.12% | 40/55 | 69.14% | 康华生物 | 96.08% | 行业排名> |
| 2023-12-31 | 51.48% | -1.24% | 2.86% | 38/55 | 68.02% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 50.05% | 0.75% | 2.67% | 36/55 | 68.07% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 48.75% | 2.9% | 0.7% | 37/55 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
| 2023-03-31 | 48.41% | 6.13% | -7.13% | 36/55 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-12-31 | 52.13% | 13.14% | 4.94% | 39/55 | 68.17% | 我武生物 | 95.39% | 行业排名> |
| 2022-09-30 | 49.67% | 4.75% | 4.86% | 38/55 | 71.28% | 我武生物 | 95.63% | 行业排名> |
| 2022-06-30 | 47.37% | 2.03% | 3.85% | 40/55 | 69.18% | 我武生物 | 95.75% | 行业排名> |
| 2022-03-31 | 45.61% | 6.87% | -1% | 36/55 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
| 2021-12-31 | 46.07% | -5.63% | -2.84% | 44/55 | 72.1% | 百奥泰 | 95.74% | 行业排名> |
| 2021-09-30 | 47.42% | -2.06% | 2.14% | 40/55 | 73.87% | 我武生物 | 95.89% | 行业排名> |
| 2021-06-30 | 46.43% | -1.5% | 8.78% | 41/55 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
| 2021-03-31 | 42.68% | -2.24% | -12.57% | 32/55 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
| 2020-12-31 | 48.82% | -6.72% | 0.83% | 38/55 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
| 2020-09-30 | 48.42% | -10.09% | 2.72% | 31/55 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
| 2020-06-30 | 47.14% | -10.68% | 7.96% | 38/55 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
| 2020-03-31 | 43.66% | -10.61% | -16.58% | 27/55 | 70.26% | 我武生物 | 95.6% | 行业排名> |
| 2019-12-31 | 52.34% | -1.85% | -2.81% | 34/55 | 72.44% | 我武生物 | 96.43% | 行业排名> |
| 2019-09-30 | 53.85% | 0.84% | 2.04% | 22/55 | 70.09% | 我武生物 | 96.51% | 行业排名> |
| 2019-06-30 | 52.78% | -0.88% | 8.04% | 21/55 | 69.35% | 我武生物 | 96.46% | 行业排名> |
| 2019-03-31 | 48.85% | -2.65% | -8.4% | 20/55 | 69.07% | 我武生物 | 96.44% | 行业排名> |
| 2018-12-31 | 53.33% | -6.42% | -0.15% | 31/55 | 71.54% | 康辰药业 | 95.1% | 行业排名> |
| 2018-09-30 | 53.41% | -8.55% | 0.31% | 19/55 | 67.51% | 康辰药业 | 94.98% | 行业排名> |
| 2018-06-30 | 53.24% | -12.65% | 6.11% | 20/55 | 67.2% | 康辰药业 | 94.9% | 行业排名> |
| 2018-03-31 | 50.17% | -24.56% | -11.95% | 18/55 | 65.03% | 我武生物 | 93.37% | 行业排名> |
| 2017-12-31 | 56.98% | 1.54% | -2.43% | 28/55 | -887.82% | 我武生物 | 96.35% | 行业排名> |
| 2017-09-30 | 58.4% | 6.78% | -4.19% | 16/55 | 65.93% | 我武生物 | 97% | 行业排名> |
| 2017-06-30 | 60.95% | 15.26% | -8.35% | 18/55 | 63.83% | 我武生物 | 96.96% | 行业排名> |
| 2017-03-31 | 66.51% | 44.5% | 18.52% | 10/55 | 65.37% | 我武生物 | 97.16% | 行业排名> |
| 2016-12-31 | 56.12% | 6% | 2.61% | 21/55 | 68.41% | 欧林生物 | 99.46% | 行业排名> |
| 2016-09-30 | 54.69% | -3.11% | 3.42% | 15/55 | 63.02% | 我武生物 | 95.96% | 行业排名> |
| 2016-06-30 | 52.88% | -6.87% | 14.9% | 17/55 | -3007.12% | 欧林生物 | 99.4% | 行业排名> |
| 2016-03-31 | 46.02% | -10.33% | -13.06% | 15/55 | 61.6% | 我武生物 | 95.8% | 行业排名> |
| 2015-12-31 | 52.94% | -7.27% | -6.21% | 20/55 | 65.23% | 欧林生物 | 99.33% | 行业排名> |
| 2015-09-30 | 56.44% | -1.91% | -0.6% | 14/55 | 60.32% | 我武生物 | 95.02% | 行业排名> |
| 2015-06-30 | 56.78% | -5.42% | 10.63% | 16/55 | 61.38% | 我武生物 | 94.71% | 行业排名> |
| 2015-03-31 | 51.33% | -20.85% | -10.09% | 12/55 | 57.69% | 我武生物 | 95.59% | 行业排名> |